Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.
about
M2e-Based Universal Influenza A VaccinesInfluenza virus-like particles containing M2 induce broadly cross protective immunityThe threat and prospects for control of an influenza pandemic.Development of universal influenza vaccines based on influenza virus M and NP genes.Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice.Induction of long-term protective immune responses by influenza H5N1 virus-like particles.Prospects for developing an effective particle-mediated DNA vaccine against influenza.A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.Cross-protective immunity to influenza A viruses.DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.The prospects and challenges of universal vaccines for influenzaInfluenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection.AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing proteinIn Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer ProteinEffect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoireSelf-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral ChallengeIncreased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge.Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice.Swine influenza vaccines: current status and future perspectives.Return of inactivated whole-virus vaccine for superior efficacy.DNA-based influenza vaccines as immunoprophylactic agents toward universality.Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.Vaccination induced antibodies to recombinant avian influenza A virus M2 protein or synthetic M2e peptide do not bind to the M2 protein on the virus or virus infected cells.Role of tissue protection in lethal respiratory viral-bacterial coinfection.A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection.Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.Monomeric M2e antigen in VesiVax® liposomes stimulates protection against type a strains of influenza comparable to liposomes with multimeric forms of M2e.Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.AFM study of a new carrier based on PLA and salen copolymers for gene therapy.
P2860
Q26783493-9754483D-E01C-45E9-8ED0-9A3E6678D030Q28743472-A63F7666-BDC7-4C59-BE28-831ACD707C00Q30233313-49978990-5D03-4004-BC95-6D836BC32E00Q30355116-9A32E3F1-C925-4269-9407-8A5299C0DA49Q30359355-D2DABF3F-5445-4544-B145-AA203B04468EQ30375255-55E16BFD-E459-4277-B698-0E4874727082Q30380300-407B5B9A-A516-44FA-A558-34284248C323Q30388390-4AD37FB3-3EF5-4F76-85FC-39C9FA42ED3EQ30396399-E5CE2BFA-DBE6-4E03-A22B-B01969D39839Q30407081-BCB78FF4-2DB7-41F4-948A-E5A4683B8152Q30410241-4C13E75A-65F3-4308-B5E6-4BAB66E72495Q30430703-F01E6C0E-775E-4A78-ABD9-CA62B8BB33D7Q33718356-DCD5B7B2-C780-4505-9C3B-2790E82273F9Q34019854-B692ADCE-E42E-4FE9-BD15-729EB0D2069BQ34059627-1443A684-588A-42D6-A900-92A79DA69D9FQ34126717-E5E599D3-AA06-48AF-8639-0447047A585EQ34437654-49AE07F0-3F21-4567-9544-ED00781B866DQ34629573-B75F9795-E1C3-4FBC-AB08-B4D9930ECC51Q34999946-9551C313-5471-4503-9741-09DAC70D2172Q35167037-A3E93B04-7886-4A98-B064-09BD973AA5AAQ35947917-8C019CCB-DD6D-4983-B9BF-33A4D616113BQ36104042-BB974122-582E-427B-8785-BF58FA8D192AQ36825473-01C6EBB8-D386-4631-9A47-36C2B4BAB691Q37028384-6E3DBF92-47F6-4EBE-937F-183D375C70FEQ37302777-262FFAB8-CC20-44AD-8E90-00CFDD4AECC8Q37492797-D6DAE26E-06BE-4431-A25E-3DA43227B36EQ37582869-5AF20DFA-1A57-4ED0-8F2A-386B67A7E5EEQ37749889-D6F2EC8A-B899-4C4A-B114-0ECF3D244504Q37918307-189D1F80-0BBC-4BD5-A969-E51B65071CC6Q38670879-2E3182C9-A036-4BF0-88C4-B4053B2C17BCQ39079605-CB09A8E9-3EE5-4089-B9E9-A82DB6F12425Q40092399-877B7CD5-1A4D-47A6-B693-13490D94922AQ41811188-C17EBA20-B1EF-4BBD-B9E4-BE63ADC4DA62Q41974283-FBE2A141-B550-40F2-9D7C-2AB07629EB1EQ42059898-C39AD8F8-3B9F-4F70-92F6-18909BA55A2DQ42263480-ABF7BBB4-129B-48B9-AC82-3BA7A235FA0BQ42611688-15BA59DA-DC2D-4675-A381-58D2C1B6C45BQ44504298-7E4A8629-2949-404A-8DAB-E187DF0710D0Q45358078-70B8523D-4425-48B5-9925-BD85E3533E14Q45872833-CE23ED1A-7F19-40DB-9D42-1EA36CD61102
P2860
Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Protective immunity against in ...... d containing influenza M gene.
@en
type
label
Protective immunity against in ...... d containing influenza M gene.
@en
prefLabel
Protective immunity against in ...... d containing influenza M gene.
@en
P2093
P1433
P1476
Protective immunity against in ...... d containing influenza M gene.
@en
P2093
Hamajima K
Nakajima K
Nakazawa M
P304
P356
10.1016/S0264-410X(01)00078-0
P407
P577
2001-06-01T00:00:00Z